Maternal genotype for the monocyte chemoattractant protein 1 A(-2518)G promoter polymorphism is associated with the risk of spina bifida in offspring [2]

American Journal of Medical Genetics

Volumn 140 A, Issue 10, 2006, Pages 1114-1118

  Jensen, Liselotte E ^a   Etheredge, Analee J ^b   Brown, Karen S ^a   Mitchell, Laura E ^a   Whitehead, Alexander S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

BODY TEMPERATURE; DNA EXTRACTION; FIRST TRIMESTER PREGNANCY; GENE REPLICATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HYPERTHERMIA; INFLAMMATION; INHERITANCE; LETTER; PATHOGENESIS; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGENY; PROMOTER REGION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SPINA BIFIDA;

CHEMOKINE CCL2; CHILD; FAMILY HEALTH; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINEAR MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK FACTORS; SPINAL DYSRAPHISM;

EID: 33646251594     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31212     Document Type: Letter

References (24)

1. Alonso-Villaverde C, Coll B, Parra S, Montero M, Tous M, Joven J, Masana L. 2004. Atherosclerosis in patients infected with HIV is influenced by a mutant monocyte chemoattractant protein-1 allele. Circulation 40:2204-2209.
2. Brown KS, Huang Y, Jian W, Lu Z-Y, Blair IA, Whitehead AS. 2006. Mild folate deficiency induces a pro-atherosclerotic phenotype in endothelial cells. Atherosclerosis (in press).
3. Caballero-Campo P, Dominguez F, Coloma J, Meseguer M, Remohi J, Pellicer A, Simon C. 2002. Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation. Mol Hum Reprod 8:375-384.
4. Castilla EE, Orioli IM, Lopez-Camelo JS, da Graca Dutra M. Nazer-Herrera J. 2003. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet Part A 123A:123-128.
5. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. 1998. Maternal fever and birth outcome: A prospective study. Teratology 58:251-257.
6. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube-defects by periconcetional vitamin supplementation. N Engl J Med 327:1832-1835.
7. Daly LE, Kirke PN, Molloy AM, Weir DG, Scott JM. 1995. Folate levels and neural tube defects. JAMA 21:1098-1702.
8. Detrait ER, George TM, Etchevers HC, Gilbert JR, Vekemans M, Speer MC. 2005. Human neural tube defects: Developmental biology, epidemiology and genetics. Neurotoxicol Teratol 27:515-524.
9. Lynberg MC, Khoury MJ, Lu X, Cocian T. 1994. Maternal flu, fever and risk of neural tube defects: A population-based case-control study. Am J Epidemiol 140:244-255.
10. Mersereau P, Kilker K, Carter H, Fassett E, Williams GJ, Flores A, Prue C, Williams L, Mai C, Mulinare J. 2004. Spina bifida and anencephaly before and after folic acid mandate-United States, 1995-1996 and 1999-2000. MMWR 53:362-365.
11. Milunsky A, Ulcickas M, Rothman KJ, Willet W, Jick SS, Jick H. 1992. Maternal heat exposure and neural tube defects. JAMA 268:882-885.
12. Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS. 2004. Spina bifida. Lancet 364:1885-1895.
13. MRC Vitamin Study Research Group. 1991. Prevention of neural tube defects. Lancet 338:131-137.
14. Petrini JR, Damus K, Johnston RB, Mattison DR. 1999. Knowledge and use of folic acid by women of childbearing age-United States, 1995-1998. MMWR 48:325-327.
15. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. 2002. Association of neural tube defects and folic acid food fortification in Canada. Lancet 360:2047-2048.
16. Rovin BH, Lu L, Saxena R. 1999. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259:344-348.
17. Shiota K. 1982. Neural tube defects and maternal hyperthermia in early pregnancy: Epidemiology in a human embryo population. Am J Med Genet 12:281-288.
18. Simon C, Gimeno MJ, Mercader A. Frances A, Garcia Velasco J, Remohi J. Polan ML, Pellicer A. 1996. Cytokines-adhesion molecules-invasive proteinases. The missing paracrine/autocrine link in embryonic implantation? Mol Hum Reprod 2:405-424.
19. Suarez L, Felkner M, Hendricks K. 2004. The effect of fever, febrile illnesses, and heat exposures on the risk of neural tube defects in a Texas-Mexico border population. Birth Defects Res Part A Clin Mol Teratol 70:815-819.
20. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, Horvath L. Csaszar A. 2001. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158:233-239.
21. Vermunt JK. 1997. LEM: A general program for the analysis of categorical data. Tilberg University. Tilberg, The Netherlands.
22. Walker AH, Najarian D, White DL, Jaffe JF, Kanetsky PA, Rebbeck TR. 1999. Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. Environ Health Perspect 107:517-520.
23. Weinberg CR. 1999. Allowing for missing parents in genetic studies of case-parent triads. Am J Hum Genet 64:1186-1193.
24. Weinberg CR, Wilcox AJ, Lie RT. 1998. A log-linear approach to case-parent triad data: Assessing the effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting. Am J Hum Genet 62:969-978.